These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 19065299

  • 21. Cellular membrane disruption by amyloid fibrils involved intermolecular disulfide cross-linking.
    Huang B, He J, Ren J, Yan XY, Zeng CM.
    Biochemistry; 2009 Jun 30; 48(25):5794-800. PubMed ID: 19449893
    [Abstract] [Full Text] [Related]

  • 22. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
    Hung A, Griffin MD, Howlett GJ, Yarovsky I.
    J Phys Chem B; 2009 Jul 16; 113(28):9447-53. PubMed ID: 19537801
    [Abstract] [Full Text] [Related]

  • 23. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent.
    Lu Y, Derreumaux P, Guo Z, Mousseau N, Wei G.
    Proteins; 2009 Jun 16; 75(4):954-63. PubMed ID: 19089954
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of fibril formation by a 39-residue peptide (PAPf39) from human prostatic acidic phosphatase.
    Ye Z, French KC, Popova LA, Lednev IK, Lopez MM, Makhatadze GI.
    Biochemistry; 2009 Dec 08; 48(48):11582-91. PubMed ID: 19902966
    [Abstract] [Full Text] [Related]

  • 25. Probing dynamics within amyloid fibrils using a novel capping method.
    Platt GW, Xue WF, Homans SW, Radford SE.
    Angew Chem Int Ed Engl; 2009 Dec 08; 48(31):5705-7. PubMed ID: 19557778
    [No Abstract] [Full Text] [Related]

  • 26. Preventing amyloid formation by catching unfolded transmembrane segments.
    Johansson H, Nerelius C, Nordling K, Johansson J.
    J Mol Biol; 2009 Jun 05; 389(2):227-9. PubMed ID: 19376131
    [Abstract] [Full Text] [Related]

  • 27. Human and rodent amyloid-beta peptides differentially bind heme: relevance to the human susceptibility to Alzheimer's disease.
    Atamna H, Frey WH, Ko N.
    Arch Biochem Biophys; 2009 Jul 01; 487(1):59-65. PubMed ID: 19454279
    [Abstract] [Full Text] [Related]

  • 28. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A, Hornemann S, Aguzzi A, Zenobi R.
    J Mass Spectrom; 2009 Jun 01; 44(6):965-77. PubMed ID: 19283723
    [Abstract] [Full Text] [Related]

  • 29. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G, Ruchala P, Teplow DB.
    Biochemistry; 2009 Dec 08; 48(48):11329-31. PubMed ID: 19877710
    [Abstract] [Full Text] [Related]

  • 30. Characterization of the heterogeneity and specificity of interpolypeptide interactions in amyloid protofibrils by measurement of site-specific fluorescence anisotropy decay kinetics.
    Jha A, Udgaonkar JB, Krishnamoorthy G.
    J Mol Biol; 2009 Oct 30; 393(3):735-52. PubMed ID: 19716830
    [Abstract] [Full Text] [Related]

  • 31. Biochemical analysis of amyloid.
    Shinoda T, Takenawa T, Kametani Y.
    Clin Dermatol; 1990 Oct 30; 8(2):87-101. PubMed ID: 1699648
    [No Abstract] [Full Text] [Related]

  • 32. AL 366--a glycosylated protein of kappa 1b origin in a patient with systemic amyloidosis of predominantly non-parenchymatous distribution.
    Samdal IA, Sletten K, Olsen KE, Westermark P.
    Amyloid; 2001 Jun 30; 8(2):111-4. PubMed ID: 11409032
    [No Abstract] [Full Text] [Related]

  • 33. Evolutionary conservation of the cholecystokinin/gastrin signaling system in nematodes.
    Janssen T, Meelkop E, Nachman RJ, Schoofs L.
    Ann N Y Acad Sci; 2009 Apr 30; 1163():428-32. PubMed ID: 19456378
    [Abstract] [Full Text] [Related]

  • 34. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
    Schlenzig D, Manhart S, Cinar Y, Kleinschmidt M, Hause G, Willbold D, Funke SA, Schilling S, Demuth HU.
    Biochemistry; 2009 Jul 28; 48(29):7072-8. PubMed ID: 19518051
    [Abstract] [Full Text] [Related]

  • 35. Remote homology detection using a kernel method that combines sequence and secondary-structure similarity scores.
    Wieser D, Niranjan M.
    In Silico Biol; 2009 Jul 28; 9(3):89-103. PubMed ID: 19795568
    [Abstract] [Full Text] [Related]

  • 36. [From the protein to amyloid deposit].
    Delpech M.
    Rev Med Interne; 2001 Jun 28; 22 Suppl 1():8s-9s. PubMed ID: 11439443
    [No Abstract] [Full Text] [Related]

  • 37. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA, Ecroyd H, Dehle FC, Musgrave IF, Carver JA.
    J Mol Biol; 2009 Sep 25; 392(3):689-700. PubMed ID: 19616561
    [Abstract] [Full Text] [Related]

  • 38. Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic.
    Velkova A, Tatarek-Nossol M, Andreetto E, Kapurniotu A.
    Angew Chem Int Ed Engl; 2008 Sep 25; 47(37):7114-8. PubMed ID: 18688904
    [No Abstract] [Full Text] [Related]

  • 39. The Arabidopsis thaliana putative sialyltransferase resides in the Golgi apparatus but lacks the ability to transfer sialic acid.
    Daskalova SM, Pah AR, Baluch DP, Lopez LC.
    Plant Biol (Stuttg); 2009 May 25; 11(3):284-99. PubMed ID: 19470101
    [Abstract] [Full Text] [Related]

  • 40. Anti-amyloid activity of the C-terminal domain of proSP-C against amyloid beta-peptide and medin.
    Nerelius C, Gustafsson M, Nordling K, Larsson A, Johansson J.
    Biochemistry; 2009 May 05; 48(17):3778-86. PubMed ID: 19281242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.